2025
Incidence Trends and Risk of Recurrent Stroke of Cervical Artery Dissections in the United States Between 2005 and 2019
Shu L, Strelecky L, de Havenon A, Nguyen T, Henninger N, Keser Z, Khan M, Siegler J, Penckofer M, Omran S, Field T, Zhou L, Xiao H, Jacobson A, Goldstein E, Stretz C, Khan F, Perelstein E, Furie K, Yaghi S. Incidence Trends and Risk of Recurrent Stroke of Cervical Artery Dissections in the United States Between 2005 and 2019. Neurology 2025, 104: e213548. PMID: 40173376, PMCID: PMC11966527, DOI: 10.1212/wnl.0000000000213548.Peer-Reviewed Original ResearchConceptsAverage annual percent changeClinical Modification</i>State-level dataAcute ischemic strokeIncidence trendsUS Census dataCervical artery dissectionVertebral artery dissectionArtery dissectionRacial minoritiesCensus dataAnnual percent changeUnique patient identifiersSecondary prevention strategiesRisk of ischemic strokeIschemic stroke riskIschemic strokeHispanic populationRisk of acute ischemic strokeCeAD casesNational Inpatient SampleConcurrent acute ischemic strokeJoinpoint regressionEstimated annual incidenceAcute ischemic stroke risk
2024
A bibliometric analysis of inflammatory bowel disease research in the Arab world
AlMuhaidib S, Bzeizi K, AlAmeel T, Mosli M, Khoja B, Barakeh D, Alomaim W, Alqahtani S, Al-Bawardy B. A bibliometric analysis of inflammatory bowel disease research in the Arab world. Saudi Journal Of Gastroenterology 2024, 31: 146-156. PMID: 39660608, PMCID: PMC12155454, DOI: 10.4103/sjg.sjg_303_24.Peer-Reviewed Original ResearchCitation impactPublication countsBibliometric analysisResearch outputPrevalence of inflammatory bowel diseaseInflammatory bowel diseaseClarivate AnalyticsIncidence rateResearch impactInstitute for Health MetricsCitationsIncidence trendsHealth metricsIBD incidenceRising PrevalenceArab countriesGlobal ratingImproving research impactIBD researchInflammatory bowel disease researchSpearman correlationPrevalenceClarivateMetricsOutputUpdated CP*Trends: An Online Tool to Compare Cohort and Period Trends across Cancer Sites
Holford T, Chen H, Kane M, Krapcho M, Annett D, Esclamado L, Melkonyan A, Feuer E. Updated CP*Trends: An Online Tool to Compare Cohort and Period Trends across Cancer Sites. American Journal Of Epidemiology 2024, kwae398. PMID: 39475089, DOI: 10.1093/aje/kwae398.Peer-Reviewed Original ResearchCancer sitesAfrican AmericansCervical cancer incidence trendsCancer incidence trendsMortality trendsCancer incidenceIncidence trendsEffect of cohortConfidence intervalsPeriod effectsInteractive websiteCohortAmericanSample sizeScoresWhiteEffects of periodMortalityCancerC-P scoreBootstrap confidence intervalsIncidenceSEERWebsitesTrendsTrends in Invasive Melanoma Thickness in Norway, 1983-2019.
Rimal R, Robsahm T, Green A, Ghiasvand R, Rueegg C, Bassarova A, Gjersvik P, Weiderpass E, Aalen O, Møller B, Perrier F, Veierød M. Trends in Invasive Melanoma Thickness in Norway, 1983-2019. Acta Dermato Venereologica 2024, 104: adv26110. PMID: 39221835, DOI: 10.2340/actadv.v104.26110.Peer-Reviewed Original ResearchConceptsLong-term incidence trendsCancer Registry of NorwayIncidence time trendsTumor thicknessCancer RegistryIncidence trendsBirth cohortTime trendsPrevention strategiesMelanoma occurrenceAge groupsMelanoma RegistryT categoryMelanoma thicknessT1 melanomasPathology reportsYounger patientsAnatomical sitesIncreased incidenceMelanomaSex differencesTumorIncidencePatientsMenBreast cancer incidence trends in Golestan, Iran: An age-period-cohort analysis by ethnic region, 2004-2018
Ghasemi-Kebria F, Fazel A, Semnani S, Etemadi A, Naeimi-Tabiei M, Hasanpour-Heidari S, Salamat F, Jafari-Delouie N, Sedaghat S, Sadeghzadeh H, Akbari M, Mehrjerdian M, Weiderpass E, Roshandel G, Bray F, Malekzadeh R. Breast cancer incidence trends in Golestan, Iran: An age-period-cohort analysis by ethnic region, 2004-2018. Cancer Epidemiology 2024, 89: 102525. PMID: 38228040, DOI: 10.1016/j.canep.2024.102525.Peer-Reviewed Original ResearchAge-standardized incidence rateAge-period-cohortIncidence rate ratiosAge-period-cohort analysisIncidence trendsCalculated age-standardized incidence ratesBreast cancer incidence trendsTrends of breast cancerCohort effectsNon-linear cohort effectsIncidence rateFemale breast cancer casesCancer incidence trendsBreast cancer incidenceAnnual percentage changeIncreased IRRsRural areasBreast cancer casesBreast cancerCancer incidenceDiagnosis yearReproductive factorsBirth cohortCancer casesRate ratios
2023
US and Global Epidemiology and Incidence Rates of Lung Cancer
DeBiasi E. US and Global Epidemiology and Incidence Rates of Lung Cancer. Respiratory Medicine 2023, 1-24. DOI: 10.1007/978-3-031-38412-7_1.Peer-Reviewed Original ResearchIncidence rate of lung cancerIncidence rateRate of lung cancerLung cancer screeningCancer screeningIncidence trendsTobacco useSmoking cessationE-cigarettesRisk factorsGlobal epidemiologyOccupational exposureLung cancerSex-SpecificRegional variationCancerSmokingIncidenceEpidemiologyLung diseaseCessationMortalityOutcomesScreeningLungGlobal, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
Collaborators G, Wu D, Jin Y, Xing Y, Abate M, Abbasian M, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abd-Allah F, Abdelmasseh M, Abdollahifar M, Abdulah D, Abedi A, Abedi V, Abidi H, Aboagye R, Abolhassani H, Abuabara K, Abyadeh M, Addo I, Adeniji K, Adepoju A, Adesina M, Adnani Q, Afarideh M, Aghamiri S, Agodi A, Agrawal A, Arriagada C, Ahmad A, Ahmad D, Ahmad S, Ahmad S, Ahmadi A, Ahmed A, Ahmed A, Aithala J, Ajadi A, Ajami M, Akbarzadeh-Khiavi M, Alahdab F, AlBataineh M, Alemi S, Al-Gheethi A, Ali L, Alif M, Almazan J, Almustanyir S, Alqahtani J, Alqasmi I, Altaf I, Alvis-Guzman N, Alvis-Zakzuk N, Al-Worafi Y, Aly H, Amani R, Amu H, Amusa G, Andrei C, Ansar A, Ansariniya H, Anyasodor A, Arabloo J, Arefnezhad R, Arulappan J, Asghari-Jafarabadi M, Ashraf T, Atata J, Athari S, Atlaw D, Atout M, Aujayeb A, Awan A, Ayatollahi H, Azadnajafabad S, Azzam A, Badawi A, Badiye A, Bagherieh S, Baig A, Bantie B, Barchitta M, Bardhan M, Barker-Collo S, Barone-Adesi F, Batra K, Bayileyegn N, Behnoush A, Belgaumi U, Bemanalizadeh M, Bensenor I, Beyene K, Bhagavathula A, Bhardwaj P, Bhaskar S, Bhat A, Bitaraf S, Bitra V, Boloor A, Bora K, Botelho J, Buchbinder R, Calina D, Cámera L, Carvalho A, Chan J, Chattu V, Abebe E, Chichagi F, Choi S, Chou T, Chu D, Coberly K, Costa V, Couto R, Cruz-Martins N, Dadras O, Dai X, Damiani G, Dascalu A, Dashti M, Debela S, Dellavalle R, Demetriades A, Demlash A, Deng X, Desai H, Desai R, Dewan S, Dey S, Dharmaratne S, Diaz D, Dibas M, Dinis-Oliveira R, Diress M, Chi T, Doan D, Dodangeh M, Dodangeh M, Dongarwar D, Dube J, Dziedzic A, Ed-Dra A, Edinur H, Eissazade N, Ekholuenetale M, Ekundayo T, Elemam N, Elhadi M, Elmehrath A, Elmeligy O, Emamverdi M, Emeto T, Esayas H, Eshetu H, Etaee F, Fagbamigbe A, Faghani S, Fakhradiyev I, Fatehizadeh A, Fathi M, Feizkhah A, Fekadu G, Fereidouni M, Fereshtehnejad S, Fernandes J, Ferrara P, Fetensa G, Filip I, Fischer F, Foroutan B, Foroutan M, Fukumoto T, Ganesan B, Gemeda B, Ghamari S, Ghasemi M, Gholamalizadeh M, Gill T, Gillum R, Goldust M, Golechha M, Goleij P, Golinelli D, Goudarzi H, Guan S, Guo Y, Gupta B, Gupta V, Gupta V, Haddadi R, Hadi N, Halwani R, Haque S, Hasan I, Hashempour R, Hassan A, Hassan T, Hassanzadeh S, Hassen M, Haubold J, Hayat K, Heidari G, Heidari M, Heidari-Soureshjani R, Herteliu C, Hessami K, Hezam K, Hiraike Y, Holla R, Hosseini M, Huynh H, Hwang B, Ibitoye S, Ilic I, Ilic M, Iranmehr A, Iravanpour F, Ismail N, Iwagami M, Iwu C, Jacob L, Jafarinia M, Jafarzadeh A, Jahankhani K, Jahrami H, Jakovljevic M, Jamshidi E, Jani C, Janodia M, Jayapal S, Jayaram S, Jeganathan J, Jonas J, Joseph A, Joseph N, Joshua C, Vaishali K, Kaambwa B, Kabir A, Kabir Z, Kadashetti V, Kaliyadan F, Kalroozi F, Kamal V, Kandel A, Kandel H, Kanungo S, Karami J, Karaye I, Karimi H, Kasraei H, Kazemian S, Kebede S, Keikavoosi-Arani L, Keykhaei M, Khader Y, Khajuria H, Khamesipour F, Khan E, Khan I, Khan M, Khan J, Khan M, Khan M, Khatatbeh H, Khatatbeh M, Khateri S, Kashani H, Kim M, Kisa A, Kisa S, Koh H, Kolkhir P, Korzh O, Kotnis A, Koul P, Koyanagi A, Krishan K, Kuddus M, Kulkarni V, Kumar N, Kundu S, Kurmi O, La Vecchia C, Lahariya C, Laksono T, Lám J, Latief K, Lauriola P, Lawal B, Le T, Le T, Lee M, Lee S, Lee W, Lee Y, Lenzi J, Levi M, Li W, Ligade V, Lim S, Liu G, Liu X, Llanaj E, Lo C, Machado V, Maghazachi A, Mahmoud M, A. T, Majeed A, Sanaye P, Makram O, Rad E, Malhotra K, Malik A, Malik I, Mallhi T, Malta D, Mansournia M, Mantovani L, Martorell M, Masoudi S, Masoumi S, Mathangasinghe Y, Mathews E, Mathioudakis A, Maugeri A, Mayeli M, Medina J, Meles G, Mendes J, Menezes R, Mestrovic T, Michalek I, de Sá A, Mihretie E, Minh L, Mirfakhraie R, Mirrakhimov E, Misganaw A, Mohamadkhani A, Mohamed N, Mohammadi F, Mohammadi S, Mohammed S, Mohammed S, Mohan S, Mohseni A, Mokdad A, Momtazmanesh S, Monasta L, Moni M, Moniruzzaman, Moradi Y, Morovatdar N, Mostafavi E, Mousavi P, Mukoro G, Mulita A, Mulu G, Murillo-Zamora E, Musaigwa F, Mustafa G, Muthu S, Nainu F, Nangia V, Swamy S, Natto Z, Navaraj P, Nayak B, Nazri-Panjaki A, Negash H, Nematollahi M, Nguyen D, Nguyen H, Nguyen H, Nguyen P, Nguyen V, Niazi R, Nikolouzakis T, Nnyanzi L, Noreen M, Nzoputam C, Nzoputam O, Oancea B, Oh I, Okati-Aliabad H, Okonji O, Okwute P, Olagunju A, Olatubi M, Olufadewa I, Ordak M, Otstavnov N, Owolabi M, Mahesh P, Padubidri J, Pak A, Pakzad R, Palladino R, Pana A, Pantazopoulos I, Papadopoulou P, Pardhan S, Parthasarathi A, Pashaei A, Patel J, Pathan A, Patil S, Paudel U, Pawar S, Pedersini P, Pensato U, Pereira D, Pereira J, Pereira M, Pereira R, Peres M, Perianayagam A, Perna S, Petcu I, Pezeshki P, Pham H, Philip A, Piradov M, Podder I, Podder V, Poddighe D, Prates E, Qattea I, Radfar A, Raee P, Rafiei A, Raggi A, Rahim F, Rahimi M, Rahimifard M, Rahimi-Movaghar V, Rahman O, Rahman M, Rahman M, Rahman M, Rahmani A, Rahmani M, Rahmani S, Rahmanian V, Ramasubramani P, Rancic N, Rao I, Rashedi S, Rashid A, Ravikumar N, Rawaf S, Redwan E, Rezaei N, Rezaei N, Rezaei N, Rezaeian M, Ribeiro D, Rodrigues M, Rodriguez J, Roever L, Romero-Rodríguez E, Saad A, Saddik B, Sadeghian S, Saeed U, Safary A, Safdarian, Safi S, Saghazadeh A, Sagoe D, Sharif-Askari F, Sharif-Askari N, Sahebkar A, Sahoo H, Sahraian M, Sajid M, Sakhamuri S, Sakshaug J, Saleh M, Salehi L, Salehi S, Farrokhi A, Samadzadeh S, Samargandy S, Samieefar N, Samy A, Sanadgol N, Sanjeev R, Sawhney M, Saya G, Schuermans A, Senthilkumaran S, Sepanlou S, Sethi Y, Shafie M, Shah H, Shahid I, Shahid S, Shaikh M, Sharfaei S, Sharma M, Shayan M, Shehata H, Sheikh A, Shetty J, Shin J, Shirkoohi R, Shitaye N, Shivakumar K, Shivarov V, Shobeiri P, Siabani S, Sibhat M, Siddig E, Simpson C, Sinaei E, Singh H, Singh I, Singh J, Singh P, Singh S, Siraj S, Al Mamun Sohag A, Solanki R, Solikhah S, Solomon Y, Soltani-Zangbar M, Sun J, Szeto M, Tabarés-Seisdedos R, Tabatabaei S, Tabish M, Taheri E, Tahvildari A, Talaat I, Tamuzi J, Tan K, Tat N, Oliaee R, Tavasol A, Temsah M, Thangaraju P, Tharwat S, Tibebu N, Ticoalu J, Tillawi T, Tiruye T, Tiyuri A, Tovani-Palone M, Tripathi M, Tsegay G, Tualeka A, Ty S, Ubah C, Ullah S, Ullah S, Umair M, Umakanthan S, Upadhyay E, Vahabi S, Vaithinathan A, Tahbaz S, Valizadeh R, Varthya S, Vasankari T, Venketasubramanian N, Verras G, Villafañe J, Vlassov V, Vo D, Waheed Y, Waris A, Welegebrial B, Westerman R, Wickramasinghe D, Wickramasinghe N, Willekens B, Woldegeorgis B, Woldemariam M, Xiao H, Yada D, Yahya G, Yang L, Yazdanpanah F, Yon D, Yonemoto N, You Y, Zahir M, Zaidi S, Zangiabadian M, Zare I, Zeineddine M, Zemedikun D, Zeru N, Zhang C, Zhao H, Zhong C, Zielińska M, Zoladl M, Zumla A, Guo C, Tam L. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. EClinicalMedicine 2023, 64: 102193. PMID: 37731935, PMCID: PMC10507198, DOI: 10.1016/j.eclinm.2023.102193.Peer-Reviewed Original ResearchAge-standardized incidence ratesAverage annual percent changeInflammatory bowel diseaseRheumatoid arthritisBowel diseaseAtopic dermatitisIncident casesMultiple sclerosisGlobal burdenInflammatory diseasesHighest age-standardized incidence ratesImmune-mediated inflammatory diseasesHigh-income North AmericaDisease StudySichuan Provincial People's HospitalDisease Study 2019Standardized incidence ratesHigh SDI regionsAnnual percent changePeople's HospitalSDI regionsIncidence rateIncidence trendsNational incidenceArthritis
2021
Incidence trends of major depressive disorder in China: an age-period-cohort modeling study
He J, Ouyang F, Li L, Qiu D, Li Y, Xiao S. Incidence trends of major depressive disorder in China: an age-period-cohort modeling study. Journal Of Affective Disorders 2021, 288: 10-16. PMID: 33839553, DOI: 10.1016/j.jad.2021.03.075.Peer-Reviewed Original ResearchConceptsYears age groupCohort effectsIncidence rateIncidence trendsMDD incidence ratesRate ratiosAge-standardized incidence rateGlobal Burden of Disease StudyAge groupsAge-period-cohort analysisMajor depressive disorder dataPeriod rate ratiosBurden of Disease StudyCohort rate ratiosMajor depressive disorderLongitudinal age curvesPublic health problemDepressive disorderBirth cohortMDD incidenceNet driftGlobal burdenHealth problemsIncidence dataDisease Study
2020
Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States
Menzies NA, Bellerose M, Testa C, Swartwood N, Malyuta Y, Cohen T, Marks SM, Hill AN, Date AA, Maloney SA, Bowden SE, Grills AW, Salomon JA. Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States. American Journal Of Respiratory And Critical Care Medicine 2020, 202: 1567-1575. PMID: 32645277, PMCID: PMC7706168, DOI: 10.1164/rccm.202003-0526oc.Peer-Reviewed Original ResearchConceptsGlobal TB controlTB incidence trendsEnd TB StrategyTB controlTB casesIncidence trendsEconomic burdenWorld Health Organization's End TB StrategyTB incidence rateGlobal tuberculosis controlHigh-burden countriesTotal economic burdenMajor health benefitsBase case scenarioBirth countryTB incidenceTB epidemiologyTuberculosis controlTB StrategyIncidence rateHealthcare costsIncidence reductionInfection riskTuberculosisSubstantial healthRetrograde Type A Aortic Dissection after Thoracic Endovascular Aortic Repair: Incidence, Time Trends and Risk Factors
Wang L, Zhao Y, Zhang W, Shu X, Wang E, Guo D, Fu W. Retrograde Type A Aortic Dissection after Thoracic Endovascular Aortic Repair: Incidence, Time Trends and Risk Factors. Seminars In Thoracic And Cardiovascular Surgery 2020, 33: 639-653. PMID: 33181306, DOI: 10.1053/j.semtcvs.2020.11.010.Peer-Reviewed Original ResearchConceptsRetrograde Type A Aortic DissectionThoracic endovascular aortic repairIncidence of retrograde type A aortic dissectionType A Aortic DissectionType B aortic dissectionA Aortic DissectionEndovascular aortic repairB aortic dissectionAortic repairStent graftRisk factorsIncidence rateOverall pooled rateOversizing rateIncidence trendsDissectionLinear regression analysisMeta-analysisTime trendsDesign of stent-graftsIncidenceAverage incidencePatientsRegression analysisRepairTime Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States
Menzies NA, Swartwood N, Testa C, Malyuta Y, Hill AN, Marks SM, Cohen T, Salomon JA. Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States. Epidemiology 2020, 32: 70-78. PMID: 33009253, PMCID: PMC7707158, DOI: 10.1097/ede.0000000000001271.Peer-Reviewed Original ResearchConceptsLatent TB infectionMycobacterium tuberculosis infectionTB infectionTuberculosis infectionTB natural historyRisk of tuberculosisMost TB casesRate of progressionYounger age groupsLower future riskTransmission dynamic modelTB casesTB riskPrevalent infectionProgression riskLifetime riskRisk factorsIncidence trendsClinical diseaseCumulative riskGeneral populationAverage ageNew infectionsUS populationAge groups
2019
Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015
Cleveland AA, Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Saadeh K, Pemmaraju M, Higgins K, Ehlers S, Scahill M, Jones M, Querec T, Markowitz LE, Unger ER, Group H. Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015. International Journal Of Cancer 2019, 146: 810-818. PMID: 30980692, PMCID: PMC9112013, DOI: 10.1002/ijc.32340.Peer-Reviewed Original ResearchConceptsCervical intraepithelial neoplasiaIncidence rateIncidence trendsAge groupsHuman papillomavirus vaccinationPopulation-based surveillanceHigh-risk typesHuman papillomavirus typesYears age groupGrade 3 casesOlder age groupsCIN3 casesPapillomavirus vaccinationQuadrivalent vaccineCIN3 lesionsHPV typesMedian ageVaccine eraIntraepithelial neoplasiaCervical cancerPrimary preventionCervical adenocarcinomaVaccine preventionCervical precancerPapillomavirus types
2017
Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data
Gordon-Dseagu VL, Devesa SS, Goggins M, Stolzenberg-Solomon R. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. International Journal Of Epidemiology 2017, 47: 427-439. PMID: 29149259, PMCID: PMC5913617, DOI: 10.1093/ije/dyx232.Peer-Reviewed Original ResearchConceptsPancreatic cancer incidence ratesCancer incidence ratesHistologic typeAnnual percent changeIncidence ratePancreatic cancerEnd Results (SEER) population-based dataLifestyle risk factorsEnd Results registryPopulation-based dataPancreatic cancer ratesCancer incidence trendsMucinous adenocarcinomaHistologic subgroupsPancreatic adenocarcinomaRisk factorsDuctal adenocarcinomaIncidence trendsCancer ratesEndocrine cancersCystic carcinomaAdenocarcinomaPercent changeYounger ageHispanic males
2015
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.
Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D'Souza G, Engels EA, Hessol NA, Brooks JT, Burchell AN, Gill MJ, Goedert JJ, Hogg R, Horberg MA, Kirk GD, Kitahata MM, Korthuis PT, Mathews WC, Mayor A, Modur SP, Napravnik S, Novak RM, Patel P, Rachlis AR, Sterling TR, Willig JH, Justice AC, Moore RD, Dubrow R. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Annals Of Internal Medicine 2015, 163: 507-18. PMID: 26436616, PMCID: PMC4711936, DOI: 10.7326/m14-2768.Peer-Reviewed Original ResearchConceptsAge 75 yearsNon-Hodgkin lymphomaCumulative cancer incidenceCumulative incidenceLung cancerKaposi's sarcomaCalendar trendsCohort studyHIV statusHodgkin's lymphomaCancer incidenceLiver cancerNorth American AIDS Cohort CollaborationOral cavity/pharyngeal cancerHigher cumulative incidenceMortality rate trendsCohort CollaborationAnal cancerAntiretroviral therapyPharyngeal cancerSmoking cessationColorectal cancerLifetime riskIncidence trendsUninfected adults
2009
A Birth Cohort Analysis of the Incidence of Papillary Thyroid Cancer in the United States, 1973–2004
Zhu C, Zheng T, Kilfoy BA, Han X, Ma S, Ba Y, Bai Y, Wang R, Zhu Y, Zhang Y. A Birth Cohort Analysis of the Incidence of Papillary Thyroid Cancer in the United States, 1973–2004. Thyroid 2009, 19: 1061-1066. PMID: 19732011, PMCID: PMC2833179, DOI: 10.1089/thy.2008.0342.Peer-Reviewed Original ResearchConceptsPapillary thyroid cancerBirth-cohort patternThyroid cancerIncidence trendsCohort patternsNational Cancer Institute's SurveillanceCohort modelingEnd Results ProgramBirth cohort effectsObserved incidence trendsBirth cohort analysisPapillary thyroid carcinomaSmall thyroid nodulesCohort-related changesObserved time trendsPeriod effectsResults ProgramCohort analysisThyroid carcinomaBirth cohortIncidence patternsThyroid nodulesCancerIncidenceStudy period
2008
Malignant Breast Cancer in Children: A Review of 75 Patients
Gutierrez JC, Housri N, Koniaris LG, Fischer AC, Sola JE. Malignant Breast Cancer in Children: A Review of 75 Patients. Journal Of Surgical Research 2008, 147: 182-188. PMID: 18498867, DOI: 10.1016/j.jss.2008.03.026.Peer-Reviewed Original ResearchConceptsMalignant breast tumorsBreast tumorsPediatric patientsSarcomatous tumorsAdjuvant radiation therapyEnd Results registryAge-adjusted incidenceMalignant breast diseaseMalignant breast cancerCommon histologyAdvanced diseaseLocalized diseaseMetastatic diseaseSurgical resectionCarcinoma patientsPrimary diseaseSarcoma patientsPhyllodes tumorMalignant diseaseSubgroup analysisBreast diseaseCarcinoma groupInvasive diseaseBreast malignancyIncidence trends
1996
A MODEL FOR THE EFFECT OF CIGARETTE SMOKING ON LUNG CANCER INCIDENCE IN CONNECTICUT
HOLFORD T, ZHANG Z, ZHENG T, MCKAY L. A MODEL FOR THE EFFECT OF CIGARETTE SMOKING ON LUNG CANCER INCIDENCE IN CONNECTICUT. Statistics In Medicine 1996, 15: 565-580. PMID: 8731001, DOI: 10.1002/(sici)1097-0258(19960330)15:6<565::aid-sim185>3.0.co;2-t.Peer-Reviewed Original ResearchConceptsLung cancer incidenceCancer incidenceIncidence rateLung cancer incidence ratesLung cancer incidence trendsEffect of smokingCancer incidence ratesCancer incidence trendsCohort studyCurrent smokersLevel of exposureMale smokersSmoking historySmoking subgroupsSmoking informationCigarette smokingMean durationSmoking prevalenceIncidence trendsSmokersSmokingPrevalenceCohort effectsAge distributionIncidence
1991
National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups.
Rosenberg PS, Gail MH, Schrager LK, Vermund SH, Creagh-Kirk T, Andrews EB, Winkelstein W, Marmor M, Des Jarlais DC, Biggar RJ. National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1991, 4: 392-401. PMID: 2007974.Peer-Reviewed Original ResearchConceptsIntravenous drug usersAIDS incidence trendsIncidence trendsDrug usersHeterosexual contactSevere immunodeficiencyHeterosexual intravenous drug usersHuman immunodeficiency virus (HIV) infectionFavorable trendTransmission groupImmunodeficiency virus infectionIncidence of AIDSCases of AIDSZidovudine therapyTransfusion recipientsVirus infectionNumber of casesZidovudineNew York CityEarly cessationTherapyAIDSMenGay menSan Francisco
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply